Augmedix, Inc. (NASDAQ:AUGX) Insider Sells $97,377.54 in Stock

Augmedix, Inc. (NASDAQ:AUGX) insider Ian Shakil sold 24,778 shares of the business’s stock in a transaction dated Thursday, April 11th. The stock was sold at an average price of $3.93, for a total transaction of $97,377.54. Following the completion of the transaction, the insider now owns 3,000 shares of the company’s stock, valued at $11,790. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Ian Shakil also recently made the following trade(s):

• On Friday, April 5th, Ian Shakil sold 51,387 shares of Augmedix stock. The stock was sold at an average price of $4.03, for a total value of $207,089.61.
• On Monday, April 8th, Ian Shakil sold 37,780 shares of Augmedix stock. The stock was sold at an average price of $3.97, for a total value of $149,986.60.
• On Wednesday, April 3rd, Ian Shakil sold 45,906 shares of Augmedix stock. The stock was sold at an average price of $4.11, for a total value of $188,673.66.
• On Monday, April 1st, Ian Shakil sold 58,978 shares of Augmedix stock. The stock was sold at an average price of $3.91, for a total value of $230,603.98.
• On Thursday, March 28th, Ian Shakil sold 31,994 shares of Augmedix stock. The stock was sold at an average price of $4.06, for a total value of $129,895.64.

Augmedix Price Performance

Shares of NASDAQ AUGX opened at $3.81 on Friday. The business’s 50 day moving average price is $4.13 and its 200 day moving average price is $4.82. The firm has a market cap of $185.70 million, a P/E ratio of -8.47 and a beta of -0.16. Augmedix, Inc. has a 52 week low of $1.50 and a 52 week high of $6.25. The company has a quick ratio of 2.41, a current ratio of 2.41 and a debt-to-equity ratio of 0.66.

Augmedix (NASDAQ:AUGX) last issued its earnings results on Monday, March 18th. The company reported ($0.09) EPS for the quarter. The firm had revenue of $12.68 million during the quarter, compared to analysts’ expectations of $12.30 million. Augmedix had a negative net margin of 42.74% and a negative return on equity of 308.50%. On average, sell-side analysts expect that Augmedix, Inc. will post -0.51 earnings per share for the current year.

Institutional Investors Weigh In On Augmedix

Hedge funds have recently bought and sold shares of the stock. Acadian Asset Management LLC purchased a new stake in Augmedix in the 3rd quarter worth approximately $48,000. Symmetry Peak Management LLC purchased a new stake in Augmedix in the 4th quarter worth approximately $88,000. Worth Venture Partners LLC purchased a new stake in Augmedix in the 3rd quarter worth approximately $83,000. Thompson Davis & CO. Inc. purchased a new stake in Augmedix in the 4th quarter worth approximately $120,000. Finally, Verition Fund Management LLC purchased a new stake in Augmedix in the 4th quarter worth approximately $122,000. Hedge funds and other institutional investors own 87.11% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on AUGX shares. Maxim Group dropped their price target on Augmedix from $6.50 to $5.00 and set a “buy” rating on the stock in a research note on Tuesday, March 19th. Evercore ISI upgraded Augmedix from an “in-line” rating to an “outperform” rating and upped their target price for the company from $4.50 to $5.00 in a research report on Tuesday. Finally, B. Riley initiated coverage on Augmedix in a research report on Wednesday, April 3rd. They issued a “buy” rating and a $5.50 target price on the stock.

About Augmedix

Augmedix, Inc provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits.